Insulin glargine, recombinant Subcutaneous and Scandonest 2% L
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Scandonest 2% L and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: levonordefrin / mepivacaine
Brand name: Carbocaine 2% with Neo-Cobefrin, Polocaine Dental, Scandonest 2% L
Synonyms: Mepivacaine and Levonordefrin, Carbocaine with Neo-Cobefrin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Scandonest 3% Plain
- Insulin glargine, recombinant Subcutaneous-Scandonest L
- Insulin glargine, recombinant Subcutaneous-SCE-A
- Insulin glargine, recombinant Subcutaneous-Scheinpharm Amoxicillin
- Insulin glargine, recombinant Subcutaneous-Schiff Move Free
- Insulin glargine, recombinant Subcutaneous-Scolopamine Patch
- Scandonest 2% L-Insulin glulisine
- Scandonest 2% L-Insulin Glulisine (Cartridges and Pens)
- Scandonest 2% L-Insulin Glulisine (Vials)
- Scandonest 2% L-Insulin glulisine Subcutaneous
- Scandonest 2% L-Insulin human inhaled Inhalation
- Scandonest 2% L-Insulin human regular Injection